Asian Spectator

Men's Weekly

.

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

  • Written by PR Newswire Asia - Asian Spectator
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease

Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90%

SYDNEY, April 15, 2024 /PRNewswire/ -- Actinogen Medical...

Magazine

Angka deforestasi meningkat, bayang-bayang krisis dan bencana mengintai

● Deforestasi Indonesia meningkat tajam, terjadi di semua pulau besar, terutama Kalimantan dan Papua.● Lonjakan ekstrem turut terjadi di Aceh, Sumatera Utara, dan Sumatera Barat, berkorela...

Harga BBM ditahan: Boleh berlega hati atau hanya menunda masalah?

CC BYDampak nyata Perang Amerika Serikat dan Iran masih berlanjut, penutupan selat hormuz oleh pihak Iran melambungkan harga minyak mentah hingga US$100 per barel (senilai Rp17 juta) dan diperkirakan ...

Riset: Proyek geotermal di sejumlah daerah lanjut terus meski banyak melanggar HAM

● Terdapat banyak pelanggaran HAM dalam pengembangan proyek geotermal di Indonesia.● Riset Pusham UII di antaranya menemukan pelanggaran hak atas partisipasi, hak-hak ekonomi, sosial, dan ...